Tumor diagnostics and personalized oncology detection services for clinical labs
益善生物技术 develops hardware and software for tumor-marker detection and pathology imaging in clinical and research settings. The tech stack reveals embedded-systems engineering (C/C++, Qt, Linux, FreeRTOS, CAN, Ethernet) paired with computer-vision pipelines (OpenCV, V4L2) — a classic medical-device architecture. Active projects span glass-slide scanning, microscope imaging, and optical instrument design, while the hiring mix is heavily skewed toward sales and channel management (48 sales roles, 2 engineering), suggesting a commercial-stage company scaling field presence faster than product iteration.
益善生物技术股份有限公司 is a Guangzhou-based medical-device and diagnostics company focused on personalized oncology detection. The company develops tumor-marker detection instruments, imaging systems, and associated laboratory services for clinical institutions and medical centers. Operations span product development, clinical validation, manufacturing, and field sales across China and the Netherlands. The organization is structured around direct-to-institution sales channels and agent-based distribution networks, with ongoing investment in agent training and knowledge transfer.
Embedded C/C++ and Qt for control software; Linux, FreeRTOS, RT-Thread for real-time operation; CAN, Ethernet, USB for device communication; OpenCV and V4L2 for image processing in pathology scanners.
Guangzhou, Guangdong Province, China. The company also maintains hiring presence in the Netherlands.
Glass-slide scanning systems, microscope imaging devices, precision optical instruments, and tumor-related clinical diagnostics products for pathology labs and medical examination institutions.